Background: Major events, such as Hurricanes Irma and Maria and the coronavirus disease 2019 (COVID‐19) pandemic disrupted Puerto Rico's health system. Lack of access to colorectal cancer (CRC) screening services may have impeded timely diagnosis. The authors examined the impact of these events on CRC incidence in Puerto Rico.Methods: The Puerto Rico Central Cancer Registry database allowed the authors to obtain CRC cases from 2012 to 2021. An interrupted time‐series analysis was performed to examine changes in CRC incidence immediately after and during the periods after the hurricanes and the pandemic. Analysis periods included: pre‐hurricanes, post‐hurricanes, and post‐COVID‐19 lockdown restrictions.Results: We observed a level change of −8.3 CRC cases was observed in the month the hurricanes struck Puerto Rico, corresponding to an immediate decrease of 17.5%. After a slight upward trend, a second decline of 39.4 CRC cases was estimated after the COVID‐19 lockdown restrictions, representing an immediate change of −24.2%. By the end of the study, the estimated numbers of patients with early stage CRC patients and those aged 50–75 years did not reach the expected numbers. In addition, CRC cases in patients with late‐stage disease and in those aged younger than 50 years and aged 76 years and older exceeded the expected numbers.Conclusions: Hurricanes Irma and Maria and the COVID‐19 pandemic caused a decrease in CRC incidence in Puerto Rico. This analysis suggests that limited access to CRC screening services during these events likely hindered CRC diagnoses. To fully understand the long‐term effects, monitoring of CRC trends will be necessary in the coming years.
Cervical cancer elimination (<4 cases per 100 000) is a critical cancer prevention goal in the United States. Implementation of health policies and allocation of health resources occur at regional and state levels; therefore, understanding region- and state-specific cervical cancer incidence, mortality, and progress toward elimination—and remaining gaps—is essential. We estimated hysterectomy-corrected cervical cancer incidence, mortality, and progress toward elimination across all 50 states, the District of Columbia, and Puerto Rico. In 2021, Massachusetts was the only state nearing (4.3 per 100 000) the elimination threshold. Southeastern and Southwestern states were furthest, with the highest incidence rates in Mississippi (14.8), Louisiana (14.2), and Oklahoma (13.8). The mortality rate ranged from 6.8 (Alabama) to 1.4 (Wisconsin). In most states, cervical cancer incidence and mortality did not change from 2007-2011 to 2017-2021. Identifying and addressing regional- and state-level barriers impeding progress will be key to achieving cervical cancer elimination.
Background/Objectives: Breast cancer (BC) represents a major public health problem that is influenced by social and systemic factors. This study evaluates disparities in the BC care continuum based on health insurance type and determines whether these patterns differ according to neighborhood-level deprivation. Methods: Using the Puerto Rico Central Cancer Registry-Health Insurance Linkage Database, we conducted a retrospective cohort study of women aged ≥18 years and diagnosed with BC in Puerto Rico between 2012 and 2016. The main outcomes were diagnostic delay (>60 days) and six-year mortality. Insurance type (private, Medicare, Medicaid, and dual enrollment in Medicare and Medicaid) was the main predictor, with neighborhood deprivation as a modifier. Logistic and Cox models assessed delay and survival, adjusting for key covariates. Results: Disparities in diagnostic delays and risk of death across insurance types were most evident in areas with low to average deprivation, whereas, in neighborhoods with above-average to highest deprivation, these differences diminished for diagnostic delay and disappeared for risk of death. Conclusions: These findings reveal that neighborhood environment, an intermediary social determinant of health, may affect the timeliness and quality of care provided to women diagnosed with BC.
Background: Hospice services play an important role in end-of-life (EoL) care. In Puerto Rico, Medicaid had no provisions for hospice care until July 2024, representing a significant public health challenge. This study examined the association between hospice coverage policy and EoL outcomes among patients with cancer enrolled in Medicaid. Methods: This population-based retrospective cohort study analyzed data of cancer patients enrolled in Medicaid from the Puerto Rico Central Cancer Registry between 2011 and 2022 who died of cancer between 2016 and 2022. Hospice enrollment was categorized into timeframes before death: 1-7, 8-14, 15-30, 31-90, 91-120, and 121-180 days. We compared total costs, healthcare utilization, and death in acute settings by hospice enrollment status. Results: Of 4481 patients in the study, 21.7% were enrolled in hospice. Non-hospice-enrolled patients had higher healthcare expenditures for the last 7 ($548; 95% confidence interval [CI ]= $166 to $931), 14 ($1619; 95% CI = $894 to $2344), 30 ($3410; 95% CI = $2263 to $4557), 90 ($4896; 95% CI = $1987 to $7804), 120 ($6171; 95% CI = $61 to $12 281), and 180 ($19 291; 95% CI = $10 851 to $27 731) days than hospice-enrolled patients. Emergency department visit rates and hospitalization rates were higher for all periods (P < .05) for non-hospice-enrolled patients than for hospice-enrolled patients. Similarly, non-hospice-enrolled patients had a higher likelihood of dying in acute settings (P < .05). Conclusion: Hospice enrollment among Medicaid enrollees was associated with lower health expenditure, lower healthcare resource utilization, and a lower likelihood of mortality in an acute setting. The recent policy change to include hospice services coverage in Puerto Rico Medicaid is a positive step that must be sustained beyond 2027.
PURPOSE: Timely discussion of goals of care (GoC) between oncologists and patients with advanced cancer can improve end-of-life (EoL) decision making, ensuring that care aligns with individual preferences. However, barriers at multiple levels could limit timely EoL communication. This cross-sectional study examined oncologists' perceptions of barriers to GoC discussions regarding EoL processes among patients in Puerto Rico. METHODS: A 26-item questionnaire was distributed to oncologists in Puerto Rico, assessing three barrier domains (patient and family; physician; and systemic or external factors) and oncologists' willingness to engage in GoC discussions. Data were collected between April 2024 and January 2025. Descriptive statistics were used to summarize oncologists' characteristics. Differences in oncologists’ characteristics and willingness to engage in the decision-making process were assessed with the Mann-Whitney test (non-normally distributed data). Associations between barriers and oncologists' characteristics, such as age and training, were explored. RESULTS: A total of 60 oncologists across Puerto Rico (approximately 50% participation rate) completed the questionnaire. Over 65% identified patient- and family-related factors as the primary barriers to EoL discussions. Although 58.3% of oncologists had not received formal training in EoL, they did not perceive this as a significant barrier. Yet, those without formal training faced greater barriers. CONCLUSION: Family and patient factors emerged as the predominant barriers. Despite oncologists' willingness to engage in EoL discussions, the absence of formal training may hinder these conversations. Further research should focus on communication training and initiatives to provide oncologists, patients, and families with valuable resources for EoL decision making.
The five-year relative survival (RS) for cervical cancer in Puerto Rico and the United States (US) is less than 70%. To assess survival trends in the past decades, we compared the five-year RS of cervical cancer in Puerto Rico and in the US. Data was obtained from the Puerto Rico Central Cancer Registry and the Surveillance, Epidemiology, and End Results Program. We included microscopically confirmed cases of cervical carcinoma between 2000 and 2021. The five-year RS trends were analyzed with Joinpoint regression models using the JPSurv software, which estimated the Average Absolute Change in Survival (AAC_S). Puerto Rico showed a lower five-year RS than US overall across the study period. In the US, the AAC_S was -0.78 for patients diagnosed between 2000 and 2003 (95%CI: -1.32 to -0.23), -0.22 for 2003-2013 (95%CI: -0.36 to -0.08), and 0.25 for 2013-2021 (95%CI: 0.01-0.49). In Puerto Rico, the AAC_S was -0.03 for 2000-2011 (95%CI: -0.56-0.51), 1.71 for 2011-2016 (95%CI: 0.60-2.83), and -1.10 for 2016-2021 (95%CI: -3.12-0.92). Puerto Rico shows poorer cervical cancer five-year RS than the US. Increased five-year RS was observed in the US overall population after 2013. In Puerto Rico, improvements in five-year RS were observed after 2011, but these were halted after 2016. This finding may suggest that barriers to accessing care during periods of extreme events, such as the convergence of the 2017 hurricanes and the 2020 COVID-19 pandemic challenges, likely affected survival trends from 2016 to 2021. Future research should further characterize barriers to improve cervical cancer survival.